[Federal Register Volume 69, Number 133 (Tuesday, July 13, 2004)]
[Notices]
[Page 42058]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-15792]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Request for Applications To Determine the 
Pharmacokinetics of Clostridium Botulinum Neurotoxins A, B, C, E, and 
F, Program Announcement Number 04099

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting: Request for 
Applications To Determine the Pharmacokinetics of Clostridium Botulinum 
Neurotoxins A, B, C, E, and F, Program Announcement Number 04099.

    Name: Disease, Disability, and Injury Prevention and Control 
Special Emphasis Panel (SEP): Request for Applications to Determine 
the Pharmacokinetics of Clostridium Botulinum Neurotoxins A, B, C, 
E, and F, Program Announcement Number 04099.
    Times and Dates: 1 p.m.-1:30 p.m., July 29, 2004 (open); 1:30 
p.m.-3:30 p.m., July 29, 2004 (closed).
    Place: Teleconference number 1-877-951-9728, pass code 362242.
    Status: Portions of the meeting will be closed to the public in 
accordance with provisions set forth in section 552b(c)(4) and (6), 
title 5 U.S.C., and the Determination of the Director, Management 
Analysis and Services Office, CDC, pursuant to Public Law 92-463.
    Matters to be Discussed: The meeting will include the review, 
discussion, and evaluation of applications received in response to 
Program Announcement Number 04099.
    Contact Person for More Information: Trudy Messmer, Ph.D., 
Scientific Review Administrator, National Center for Infectious 
Diseases, CDC, 1600 Clifton Road, NE., MS-C19, Atlanta, GA 30333, 
telephone (404) 639-37706.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: July 7, 2004.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 04-15792 Filed 7-12-04; 8:45 am]
BILLING CODE 4163-18-P